Paul Hartmann AG
F:PHH2
Paul Hartmann AG
F:PHH2
Price:
223
EUR
-0.45%
Market Closed
Market Cap:
€796.1m
Relative Value
The Relative Value of one
PHH2
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 223 EUR,
Paul Hartmann AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PHH2 Relative Value
HIDDEN
Multiples Across Competitors
PHH2 Competitors Multiples
Paul Hartmann AG Competitors
Paul Hartmann AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Paul Hartmann AG
F:PHH2
|
792m EUR | 0.3 | 9.7 | 9.5 | 9.5 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
60B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
8.9T JPY | 9.8 | 35.7 | 25.7 | 30.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.6B CHF | 3.8 | 37.3 | 15.4 | 30 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
109.6B DKK | 4 | 30.9 | 14.4 | 17.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 3.4 | 35.5 | 16.1 | 20.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.2 | 13 | 21.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY | 9.4 | 26 | 23.5 | 23.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD | 1.2 | -19.7 | 19.6 | 92.4 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
3.9B CHF | 5 | 20.4 | 13.2 | 18 | |
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD | 3.2 | 40.4 | 18.4 | 30.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
